Latest News
All Times Eastern
- My husband says we’ll be ‘homeless’ if we keep renting. We’re 68 and 74 — do we buy a home instead?
- I don’t want to leave my financially irresponsible daughter my house. Is that unreasonable?
- AI has supercharged online scams: With the holidays coming, here’s what to look out for
- Opinion Another U.S.-China conflict is escalating. This one could be the most serious of all.
- Why so many people are suddenly turning to GoFundMe to help pay off student debt
- Opinion China and the U.S. are testing the limits of global trade
- Opinion How could a politician engage in large-scale deception and win? Easy. Just ask George Santos.
- 5 unforgettable towns for a winter getaway
- OPEC may be ‘panicking’ as U.N. COP28 climate talks focus on possible fossil fuel phase-out, observers say
- Opinion Here’s how to know if your mutual fund sees ESG investing clearly
to be replaced
Bristol Myers Squibb Co.
BMYUS
$
0.02
0.04%
After Hours
$
50.33
After Hours Volume:
231.52K
| Close | Chg | Chg % |
|---|---|---|
| $50.31 | 0.15 | 0.30% |
Volume: 10.12M
65 Day Avg: 13.12M
50.09
Day Range
50.54
48.25
52 Week Range
80.67
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
BMY Overview
Key Data
- Open $50.26
- Day Range 50.09 - 50.54
- 52 Week Range 48.25 - 80.67
- Market Cap $102.37B
- Shares Outstanding 2.03B
- Public Float 2.03B
- Beta 0.52
- Rev. per Employee $1.310M
- P/E Ratio 12.76
- EPS $3.94
- Yield 4.77%
- Dividend $0.60
- Ex-Dividend Date Jan 4, 2024
- Short Interest 26.8M 11/15/23
- % of Float Shorted 1.32%
- Average Volume 13.12M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 27
Full Ratings
Recent News
Biotech and Pharma Bristol Myers Squibb CEO Chris Boerner Buys Up Stock
Biotech and Pharma Bristol Myers Stock Is Slumping. One Director Bought Up Shares.
Biotech and Pharma Avidity Stock Soars on Collaboration Deal With Bristol Myers
3 Dividend Stocks Trading at 52-Week Lows
on Motley Fool
Insiders Buying Bristol-Myers Squibb And 3 Other Stocks
on Benzinga.com
Market Today: Tech Stocks Surge Amid AI Euphoria; Bristol Myers Faces Executive Departure
Market Today: Tech Stocks Surge Amid AI Euphoria; Bristol Myers Faces Executive Departure
on GuruFocus.com
Why Bristol Myers Squibb's Shares Are Gaining Today?
on Benzinga.com
Analyzing December Profit Potential for the Top 4 Pharma Stocks
on StockNews.com
Analyzing December Profit Potential for the Top 4 Pharma Stocks
on StockNews.com
3 Dirt-Cheap Stocks That Could Skyrocket
on Motley Fool
Incyte's Bullish Outlook: A Surprising Strength You Shouldn't Overlook
Incyte's Bullish Outlook: A Surprising Strength You Shouldn't Overlook
on GuruFocus.com
Insider Buying: CEO Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co
Insider Buying: CEO Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co
on GuruFocus.com
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Johnson & Johnson | $371.73B | |
| Pfizer Inc. | $162.5B | |
| Abbott Laboratories | $181.44B | |
| AbbVie Inc. | $263.56B | |
| Merck & Co. Inc. | $262.9B | |
| Novartis AG | CHF175.22B | |
| AstraZeneca PLC ADR | $196.79B | |
| AstraZeneca PLC | £156.88B | |
| Sanofi S.A. | €108.23B | |
| GSK PLC | £58.68B |